MedPath

A Prospective, Split-Face, Randomized Study Comparing a 532-nm Picosecond Laser With and Without Microlens Array in the Treatment of Solar Lentigines in Thai patients

Phase 4
Conditions
Solar lentigines
Picosecond
Fractional
Registration Number
TCTR20230417009
Lead Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
27
Inclusion Criteria

1. Asian with Fitzpatrick Skin type III-V
2. Was diagnosed by a physician as Solar lentigines by a research physician.
3. Solar lentigines are on both sides of the face, and the lesion size is greater than 6 mm.

Exclusion Criteria

1. Pregnant women
2. Patients with dermatitis, wounds, or skin infections on the face
3. Patients with a history of allergy to anesthetics and cannot use cold air during treatment.
4. Patients with other diseases related to pigmentation abnormalities, such as melasma, hori nevus, nevus of ota, freckles, etc., in the same area with solar lentigines
5. Patients with a history of solar lentigines treatment with topical medications, chemical peels, or facial lasers within three months prior to participation in the study.
6. Patients with a history of herpes on the face or suffering from herpes on the face
7. Patients with mental disorders whom a psychiatrist has diagnosed.
8. Patients considered by the researcher to be unsafe if participating in the program
9. Patients who are not allowed to take pictures for treatment evaluation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of PIH following treatment 2 weeks, 1 month, 3 months , 6 months after treatment Clinical evaluation
Secondary Outcome Measures
NameTimeMethod
Average melanin concentration Before, 2 weeks, 1 month, 3 months, 6 months after treatment Antera 3D analysis
© Copyright 2025. All Rights Reserved by MedPath